| Literature DB >> 29604588 |
Abdoh Taleb1, Khalil Ali Ahmad1, Awais Ullah Ihsan2, Jia Qu1, Na Lin1, Kamal Hezam3, Nirmala Koju1, Lei Hui1, Ding Qilong4.
Abstract
Cardiovascular diseases (CVDs) are considered as the major reason for mortality and morbidity worldwide. Substantial evidence suggests that increased oxidative stress plays a significant role in the pathogenesis of CVDs, including atherosclerosis, hypertension, vascular endothelial dysfunction and ischemic heart disease. Cellular oxidative stress results in the release of toxic free radicals by endothelial cells and vascular smooth muscle cells that interact with cell components such as protein, DNA or lipid resulting in cardiovascular pathology. Silymarin has antioxidant activities against CVDs and offers protection against oxidative stress-induced hypertension, atherosclerosis and cardiac toxicity. We present a comprehensive review regarding the oxidative stress and protective effects of silymarin in CVDs management. We also aim to provide mechanistic insight of the mechanisms of silymarin action in oxidative stress-induced CVDs.Entities:
Keywords: Antioxidants; CVDs; Oxidative stress; ROS; Silymarin
Mesh:
Substances:
Year: 2018 PMID: 29604588 DOI: 10.1016/j.biopha.2018.03.140
Source DB: PubMed Journal: Biomed Pharmacother ISSN: 0753-3322 Impact factor: 6.529